NIDA-Tobacco Regulatory Science Program (TRSP)

What We Do

With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. To better inform FDA’s regulatory authorities, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research, capitalizing on NIH’s infrastructure to support tobacco-related research and funding from FDA. Get more information about the FDA Center for Tobacco Products (FDA/CTP) research priorities.

NIDA-TRSP Office Roles

  • NIDA liaison with FDA/CTP and NIH-TRSP
  • Internal coordinating committee comprised of each NIDA division will:
    • Monitor NIH-TRSP activities and progress through the development of:
      • Provide administrative templates for NIDA staff
    • Devise Standard Operating Procedures (SOPs)
    • Help solicit nominations IC Investigator-initiated funding requests in response to periodic NIH-TRSP-based requests
    • Review Nicotine Research Cigarettes (NRC) requests, as necessary
  • Organize NIDA-TRSP-related meetings 

Current Funding Mechanisms

In collaboration with the FDA Center for Tobacco Products, NIH is increasing its portfolio to support the scientific needs of the Center. Below you will find a listing of funding opportunities that are currently accepting applications. Investigator initiated applications may also be submitted for review. Refer to the Research Priorities page for topics relevant to FDA. Interested applicants should work with their NIH Program Officials or Contact Us.

For more information about TRSP funding opportunities, please visit here.

Tobacco Centers of Regulatory Science (TCORS)

The TCORS program brings together investigators from across the country to aid in the development and evaluation of tobacco product regulations. Each TCORS application identified a targeted research goal. Taken together, the TCORS sites will increase knowledge across the full spectrum of basic and applied research on tobacco and addiction. The program also provides young investigators with training opportunities to ensure the development of the next generation of tobacco regulatory scientists. Fourteen TCORS, made up of scientists with a broad range of expertise (e.g., epidemiology, economics, toxicology, addictions, and marketing) were funded in September 2013. NIDA will programmatically manage five of the 14 funded TCORS. More information about each of these fourteen TCORS is found here

Grant Process:

Grant Schematic for R Funding Mechanisms

Grant Schematic for R Funding Mechanisms - see text below.

CSR: Center for Scientific Review
IRG: Internal Review Group
PI: Principal Investigator

R Funding Mechanism (Stepwise Process)

  1. Principal Investigator initiates research idea and develops application.
  2. Principal Investigator submits application to NIH during applicable funding cycle.
  3. Applications compliant with NIH policies are assigned for review by the Division of Receipt and Referral in the Center of Scientific Review (CSR).
  4. CSR assigns application to an NIDA and a Scientific Review Group (SRG).
  5. Approved proposals are pre-reviewed for responsiveness to the RFA with officials from the FDA/CTP, NIH-TRSP, and NIDA Program for responsiveness and scientific merit.
  6. Proposals are reviewed by a CSR-based Internal Review Group (IRG)
  7. Proposals are evaluated based on priority score; FDA funding availability; and research priorities from the FDA Center for Tobacco Products.
  8. Proposals are reviewed during NIH Institute Council sessions for final approval by NIDA Institute Director.
  9. FDA/CTP makes funding recommendations. NIH-TRSP notifies NIDA staff of funding decisions and NIDA issues and sends Notice of Award (NoA) to applicant institution/organization.
  10. IC grants management staff conducts final administrative review and negotiates award.
  11. Research Institute (NIDA) receives and manages awards.
  12. Investigator conducts research. 

FAQs on Grant Responsiveness:

Potential applicants should think about how the findings from the research they propose will inform a specific regulatory authority of FDA/CTP and fit within the FDA/CTP research priorities

For more information, please read the TRSP FAQs (PDF, 205KB). Or, email with any questions concerning grant responsiveness.

Additional Resources:

Contact/Additional Information: